5 Followers on Owler
Genevant develops nanoparticle and conjugate delivery platforms that optimizes clinical development of RNA therapeutics... Read more
OverviewNews & Insights
Genevant develops nanoparticle and conjugate delivery platforms that optimizes clinical development of RNA therapeutics... Read more
GENEVANT SCIENCES President & CEO: Bo Rode Hansen

President & CEO

Bo Rode Hansen

CEO Approval Rating

70/100

2017

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?

News

Partnership
Oct 22, 2024
Pharamceutical Technology
Editas and Genevant team up to develop gene editing therapies

Trending Companies